MPJ-14129-90171
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 805 / CO
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-20
-
2021-04-27
Dose 2 — Pfizer-BioNTech
- 2021-04-27
- 2021-04-28
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Fatigue or tirednessAdult check-in
- 2021-05-01
- 2021-05-02
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-07-29
- 2021-10-26
-
2022-04-29
Survey response — 12 months, dose 2MedDRA: SARS-CoV-2 test negative, Viral upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Upper respiratory virus; confirmed to NOT be COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: Upper respiratory virus; confirmed to NOT be COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release